Postnatal Cytokine Trajectories in Very Preterm Infants.

Samples could only be taken when a clinical lab was already needed, so not every infant had weekly blood draws and collection timing varied by unit routine and infant condition. The researchers could not control whether blood was collected by heelstick, venous stick, or arterial stick, or the time of collection. Several cytokines were too low to measure, so the study could not describe IL-1β, IL-10, IL-4, or IL-17A trajectories. Cytokines were not measured immediately after birth, so an early rise or fall could have been missed. The study excluded infants with infection and major complications, so the findings apply only to relatively stable very preterm infants born at 28 to 31 weeks PMA. Breastmilk feeding and blood transfusions were not controlled, and these could influence cytokine levels. The study did not measure neurodevelopment or clinical outcomes, so it cannot show whether a cytokine trajectory predicts impairment or neonatal complications.

The supplied publication types list NIH extramural and non-U.S. government research support. No author conflicts-of-interest statement is included in the text.

Do not use these cytokine patterns to diagnose infection, predict brain injury, or guide treatment in a preterm infant. The study excluded infected infants, did not measure neurodevelopment outcomes, and describes preliminary research trajectories.